Delivery Order SPE2DB24D1006-SPE2DB25FCEEG

Award Date 1/29/25
Potential Completion Date 2/20/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,849.85, is a delivery order for OJJAARA 200 MG TABLET UU 30S. The contract is a firm fixed price agreement with a completion date of January 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,849.85 firm fixed-price delivery order is for the supply of OJJAARA 200 MG TABLET UU 30S medical products. The contract has an ultimate completion date of February 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,684.25, is for the delivery of OJJAARA 100 MG TABLET UU 30S, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,849.85 firm fixed-price delivery order contract is for the supply of OJJAARA 200 MG TABLET UU 30S, a medical product. The contract has an ultimate completion date of February 4, 2025 and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of OJJAARA 200 MG TABLET medical products. The contract has a ceiling value of $34,331.38 and a period of performance ending on November 1, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor. This delivery order is likely part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,758.95 firm-fixed-price delivery order is for the supply of 4566598844 ! OJJAARA 200 MG TABLET UU 30S, with a period of performance through December 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $17,849.85, is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, worth $999,999,999 and running through November 2026. The contract is for the provision of 4566994742 ! OJJAARA 200 MG TABLET UU 30S, a pharmaceutical product, to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical sourcing and distribution company. The $17,212.75 order is for OJJAARA 200 MG TABLET UU 30S, a pharmaceutical product, with a completion date of March 12, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential...
This $17,165.69 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The contract is for the supply of OJJAARA 200 MG tablets, with an ultimate completion date of June 3, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,758.95, is for the delivery of OJJAARA 200 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 21, 2025 and is a firm fixed-price delivery order contract. This award is not associated with a set-aside program. AmerisourceBergen Drug...
  • SPE2DB24D1006
    Indefinite Delivery Contract
  • SPE2DB24D1006-SPE2DB25FCEEG
    Delivery Order

This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,849.85, is for the delivery of OJJAARA 200 MG TABLET UU 30S to support federal healthcare programs.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/30/25, 10:18 AM